AptarGroup outlines 35% decline in emergency medicine revenue for 2026 amid shifting pharma demand (NYSE:ATR) - Reportify

AptarGroup outlines 35% decline in emergency medicine revenue for 2026 amid shifting pharma demand (NYSE:ATR)

AptarGroup(US:ATR) Seeking Alpha·2025-11-01 00:47

网站访问技术问题 - 为确保未来正常访问网站需在浏览器中启用Javascript和cookies [1] - 启用广告拦截器可能导致访问被阻止需禁用广告拦截器并刷新页面 [1]